IFI44L and non-small cell lung carcinoma: In order to further analyze the potential functions of IFI44L in NSCLC patients, the GSEA was performed to explore the candidate pathways between the high-IFI44L group and the low-IFI44L group in the TCGA-LUAD cohort and TCGA-LUSC cohort, respectively.